Chapter 8 - A NEW DAWNThree months later, the copper brass plaque outside the penthouse corporate headquarters of Vance-Miller Bio-Research Technologies gleamed brilliantly in the midday sun.
The name Mitchell was gone—scrubbed from the glass, the letterhead, the patent filings, and the corporate history books as if it had never existed at all.
Inside the executive boardroom, the long mahogany table was surrounded by a completely new board of directors: brilliant, ethical scientists, ethical pharmacologists, and legal experts dedicated to transparency and patient safety. At the head of the table sat Dr. Catherine Hayes, newly reinstated as our Chief Scientific Officer, her career restored and her name cleared with full honors.
And beside her, holding the primary voting shares of the company, sat me.
My phone buzzed on the table. It was a brief notification from the federal marshal's office: Case #9942-A closed. Defendant Jason Mitchell sentenced to forty-five years maximum security without parole, with full asset forfeiture executed.
I looked down at my wrist, tracing my finger lightly over the faded silver line of an old scar—not with pain, not with sorrow, but as a reminder of armor forged through fire.
The door to the boardroom opened, and Daniel Brooks walked in, holding a fresh cup of black coffee and a copy of the morning financial journal.
"The stock opened up another twelve points this morning, Iris," Daniel said with a warm, approving smile, sliding the paper across the table. "You're officially listed on Forbes' list of self-made corporate leaders under visionary pioneers."
I picked up the journal, looking down at the front-page headline, where my face looked out from the page—not as a victim, not as a broken woman hiding in a gray coat, but as a survivor who had taken an empire back from the ashes.
May you like
I closed the magazine, looked up at my team, and smiled.
"Let's get to work."
